Company Analysis
Sign in

Tango Therapeutics, Inc. (TNGX)

Nasdaq: TNGX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2020
Full chart Alerts Compare
Grade5.6
◀ Past 6.2● Present 5.6▶ Future 5.2
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

8 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Tango Therapeutics, Inc.’s names, not what it holds today.

Patents granted
8
8 utility, 1976 to Dec 31, 2025
Granted in 2025
3
Against 3 in 2024 and none in 2023
Applications published
17
5 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry6
Pharmaceuticals2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Tango Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
17 published
Tango Therapeutics, Inc. its own name
US, as the owner printed on each patent
8 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 2, 202512,403,137Compounds and methods of useOrganic fine chemistryTango Therapeutics, Inc.
May 20, 202512,304,907Compounds and methods of useOrganic fine chemistryTango Therapeutics, Inc.
Apr 1, 202512,264,154Compounds and methods of useOrganic fine chemistryTango Therapeutics, Inc.
Jul 23, 202412,043,607HDAC inhibitors and therapeutic use thereofOrganic fine chemistryTango Therapeutics, Inc.
Jun 4, 202411,999,727Compounds and methods of useOrganic fine chemistryTango Therapeutics, Inc.
May 21, 202411,986,471Compounds and methods of usePharmaceuticalsTango Therapeutics, Inc.
Nov 8, 202211,492,350Compounds and methods of useOrganic fine chemistryTango Therapeutics, Inc.
Aug 3, 202111,077,101Compounds and methods of usePharmaceuticalsTango Therapeutics, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Sep 11, 20252025/0282749COMPOUNDS AND METHODS OF USEOrganic fine chemistryTango Therapeutics, Inc.
May 29, 20252025/0171432COMPOUNDS AND METHODS OF USEOrganic fine chemistryTango Therapeutics, Inc.
May 22, 20252025/0163048COMPOUNDS AND METHODS OF USEPharmaceuticalsTango Therapeutics, Inc.
May 1, 20252025/0136594COMPOUNDS AND METHODS OF USEPharmaceuticalsTango Therapeutics, Inc.
May 1, 20252025/0136570HDAC INHIBITORS AND THERAPEUTIC USE THEREOFOrganic fine chemistryTango Therapeutics, Inc.
Nov 7, 20242024/0368139NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOFPharmaceuticalsTango Therapeutics, Inc.
Aug 22, 20242024/0279219COMPOUNDS AND METHODS OF USEPharmaceuticalsTango Therapeutics, Inc. · patent 12,304,907 granted from it
Jul 11, 20242024/0228478COMPOUNDS AND METHODS OF USEPharmaceuticalsTango Therapeutics, Inc. · patent 12,264,154 granted from it
Jun 13, 20242024/0190858CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOFPharmaceuticalsTango Therapeutics, Inc.
Jun 6, 20242024/0182481PYRROLO[3,2-D]PYRIMIDINE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCEROrganic fine chemistryTango Therapeutics, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 6 · Organic fine chemistry 5.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton TNGX · research, not advice